Stock Analysis

Healthpeak Properties (DOC): Valuation Check After Monthly Dividend Shift and $1 Billion Asset Monetization Plan

Healthpeak Properties (DOC) just shook up its capital strategy by shifting to monthly dividends with a rising payout, while planning to monetize up to $1 billion of outpatient medical offices to fuel new investments.

See our latest analysis for Healthpeak Properties.

Despite the strategic shift, sentiment has been soft, with a year to date share price return of negative 18.2 percent and a one year total shareholder return of negative 18.27 percent. This suggests momentum is still under pressure even as management leans into growth.

If this healthcare focused REIT has caught your eye, it could be worth comparing it with other real estate backed names in healthcare stocks to see what the market is rewarding right now.

With shares trading at a steep discount to both analyst targets and some intrinsic value estimates despite accelerating earnings growth, is Healthpeak quietly setting up a value opportunity or is the market already discounting its future expansion?

Most Popular Narrative Narrative: 21.2% Undervalued

With Healthpeak Properties closing at $16.49 versus a narrative fair value just above $20, the gap reflects ambitious earnings and margin assumptions ahead.

The accelerating shift of surgical and specialty care from inpatient hospital settings to outpatient centers supported by anticipated regulatory changes (CMS inpatient only default reversal) is set to drive sustained tenant demand and pricing power for Healthpeak's modern, high acuity outpatient medical buildings. This should translate into increased occupancy rates and same store NOI growth.

Read the complete narrative.

Curious how modest top line growth, rising margins and a richer future earnings multiple all combine to justify that upside gap? The full narrative reveals the precise growth runway, profit step up and valuation hurdle baked into this target, plus how a lower discount rate quietly amplifies today’s fair value.

Result: Fair Value of $20.92 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, concentrated exposure to life science tenants and capital markets volatility could still derail revenue growth, pressure margins, and challenge the optimistic valuation case.

Find out about the key risks to this Healthpeak Properties narrative.

Build Your Own Healthpeak Properties Narrative

If you see the story differently or want to dig into the numbers yourself, you can build a personalized thesis in just a few minutes: Do it your way.

A great starting point for your Healthpeak Properties research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.

Looking for more smart investment angles?

Before you move on, consider scanning fresh opportunities in other corners of the market with the Simply Wall Street Screener so you are not leaving potential returns on the table.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Mobile Infrastructure for Defense and Disaster

The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.

Get the investor briefing before the next round of contracts

Sponsored On Behalf of CiTech

Valuation is complex, but we're here to simplify it.

Discover if Healthpeak Properties might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:DOC

Healthpeak Properties

A Standard & Poor’s (“S&P”) 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States (“U.S.”).

Very undervalued average dividend payer.

Weekly Picks

WO
MGPI logo
woodworthfund on MGP Ingredients ·

THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION

Fair Value:US$4035.0% undervalued
25 users have followed this narrative
4 users have commented on this narrative
8 users have liked this narrative
DO
Double_Bubbler
EVTL logo
Double_Bubbler on Vertical Aerospace ·

Why Vertical Aerospace (NYSE: EVTL) is Worth Possibly Over 13x its Current Price

Fair Value:US$6090.4% undervalued
24 users have followed this narrative
3 users have commented on this narrative
18 users have liked this narrative
TI
TickerTickle
ORCL logo
TickerTickle on Oracle ·

The Quiet Giant That Became AI’s Power Grid

Fair Value:US$389.8151.3% undervalued
46 users have followed this narrative
4 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

GA
BUKS logo
GaryB on Butler National ·

Butler National (Buks) outperforms.

Fair Value:US$3.4419.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
OS
oscargarcia
AVGO logo
oscargarcia on Broadcom ·

A tech powerhouse quietly powering the world’s AI infrastructure.

Fair Value:US$48025.0% undervalued
15 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AB
AbraxasAether
AJBU logo
AbraxasAether on Keppel DC REIT ·

Keppel DC REIT (SGX: AJBU) is a resilient gem in the data center space.

Fair Value:S$2.613.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.4% undervalued
120 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8683.7% undervalued
78 users have followed this narrative
8 users have commented on this narrative
21 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3930.1% undervalued
965 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative